GLP-1RA THERAPY IS ASSOCIATED WITH HIGHER VASCULAR REGENERATIVE CELL CONTENT AND LOWER INFLAMMATORY BURDEN IN PEOPLE LIVING WITH TYPE 2 DIABETES
A. Krishnaraj(Toronto Public Health), Hwee Teoh(St. Michael's Hospital), Y. Pan(Toronto Public Health), Ehab Bakbak(The University of Queensland), David A. Hess(Western University), Subodh Verma(St. Michael's Hospital), Adrian Quan(St. Michael's Hospital), Brian Park(Toronto Public Health)
Cited by 0
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
New Markers of Inflammation and Endothelial Cell Activation
|Circulation|2003|733
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
|New England Journal of Medicine|2024|693
Endothelial cell control of thrombosis
|BMC Cardiovascular Disorders|2015|678